Cystitis treatment with high dose chondroitin sulfate

Details for Australian Patent Application No. 2004212650 (hide)

Owner Stellar Pharmaceuticals Inc.

Inventors Hahn, Sungtack Samuel; Riehl, Peter R.

Agent Callinan

Pub. Number AU-B-2004212650

PCT Pub. Number WO2004/073584

Priority 10/367,970 19.02.03 US

Filing date 18 February 2004

Wipo publication date 2 September 2004

Acceptance publication date 23 July 2009

International Classifications

A61K 31/737 (2006.01) - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 33/14 (2006.01) Medicinal preparations containing inorganic active ingredients - Alkali metal chlorides

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/073584 Priority application(s): WO2004/073584

29 November 2007 Assignment before Grant

  Stellar International Inc. The application has been assigned to Stellar Pharmaceuticals Inc.

23 July 2009 Application Accepted

  Published as AU-B-2004212650

19 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004212654-Aleurone product and corresponding production method

2004212647-Method and apparatus for lifting sod from the top